Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation

N/AUnknownNCT01991951

Korea University Anam Hospital520 enrolled

Overview

We hypothesized that in patients with low CHADS-VASc score (2 or \< 2), there is no difference in thromboembolic or bleeding events between patients with short term warfarin therapy (2 weeks after catheter ablation) and conventional therapy (3 weeks before and 8 weeks after procedure).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

520

Conditions

Atrial Fibrillation

Interventions

warfarinDRUG

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with paroxysmal atrial fibrillation who underwent radiofrequency catheter ablation * Patients with CHADS-VASc score 2 or less than 2 Exclusion Criteria: * Patients who do not consent to the study * Permanent or persistent atrial fibrillation * Patients who have underwent prior catheter ablation for atrial fibrillation * CHADS-VASc score more than 2 * History of stroke * LVEF \<40% * Significant liver or kidney dysfunction * History of major bleeding during warfarin therapy

Locations (1)

Korea University Anam Hospital

Seoul, South Korea

RECRUITING

Outcomes

Primary Outcomes

Incidence of thromboembolic and bleeding events during 2 months

Time frame: 2 months after the procedure

Central Contacts

Jaemin Shim, MD

CONTACT

82-10-6776-1195 jshim@kumc.or.kr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.